{"id":28766,"date":"2016-11-14T12:02:23","date_gmt":"2016-11-14T11:02:23","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=28766"},"modified":"2016-11-17T17:54:03","modified_gmt":"2016-11-17T16:54:03","slug":"alimenti-speciali-per-quintiles-ims-urgono-scelte-di-nicchia","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/alimenti-speciali-per-quintiles-ims-urgono-scelte-di-nicchia\/","title":{"rendered":"Special foods, niche choices are urgently needed for Quintiles Ims"},"content":{"rendered":"

THE\"RisultatiThe turnover settles at 480 million euros but only a third<\/strong> approximately passes through local pharmacies, where consumption has reported a drop in 4% values in the last year. These are some of the figures that characterize the market of special foods (products for diabetics, protein-free, gluten-free and wholemeal) according to the analysis<\/a>\u00a0recently proposed by Quintiles Ims in its web magazine: the pharmacy, write the experts of the research company, has to deal with less competitive pricing compared to large-scale distribution, which \u00abis organized in different regions in order to accept the vouchers right many patients.<\/p>\n

It then becomes dispensable, write the Quintiles Ims experts<\/strong>, \u00abmake niche choices, both in terms of product types and in terms of patients\u00bb. In particular, it may become appropriate to equip oneself to "serve specific categories of patients in the best possible way", with the offer of services correlated to specific customer segments: personal support, medical consultancy, diagnostics, advice, etc. As far as products are concerned, however, one can start from a picture of what already exists: the pharmacy, observes Quintiles Ims, handles more than 1,500 brands in a year, "with about 300 companies operating and more than four hundred launches in the last twelve months". Select becomes the password.<\/p>\n

(AS \u2013 12\/11\/2016 \u2013 Federfarma<\/span><\/a>)<\/p>\n

Ed<\/strong><\/span>.: Foods for Special Medical Purposes (AFMS) must necessarily have a "nutritive" role, as constituents of a food ration aimed at satisfying the nutritional needs of patients in specific conditions of nutritional vulnerability<\/span>.<\/em><\/p>\n

The EU has prepared a revision of the AFMS in view of the entry into force (20 July 2016) of the regulation (EU) 609\/2013. The Ministry of Health has carried out a review to verify the effective compliance of products notified as Food for Special Medical Purposes (AFMS) with the definition given by the specific legislation. Some AFMS are payable by the NHS.<\/em><\/p>\n

The Ministry of Health has prepared national registers for foods for special medical purposes, gluten-free foods and infant formulas.<\/em><\/p>\n

Related news<\/strong>: Food Supplements and Foods for Special Medical Purposes (AFMS). EU review<\/a><\/span><\/p>\n

Ministry of Health. Revision of the AFMS in view of the entry into force of Regulation (EU) 609\/2013\u00a0<\/a><\/span><\/p>\n

Regulation (EU) 609\/2013<\/a><\/span><\/p>\n

Dietetic Foods\/Foods for specific groups<\/a><\/span><\/p>\n

Directive 2002\/46\/EC for the approximation of the laws of the Member States relating to food supplements<\/a><\/span><\/p>\n

National registers of foods for special medical purposes<\/a><\/span><\/p>\n

\u00a0Ministerial Decree June 8, 2001<\/a><\/span><\/p>\n

Powdered milk for babies: what the law says<\/a><\/span><\/p>\n

\"Risultati<\/p>\n

\"Risultati<\/p>","protected":false},"excerpt":{"rendered":"

Il giro d\u2019affari si assesta sui 480 milioni di euro ma soltanto un terzo circa passa dalle farmacie del territorio, dove i consumi denunciano nell\u2019ultimo anno un calo a valori del 4%. Sono alcune delle cifre che caratterizzano il mercato degli alimenti speciali (prodotti per diabetici, aproteici, senza glutine e integrali) secondo l\u2019analisi\u00a0proposta recentemente da …<\/p>","protected":false},"author":4,"featured_media":28772,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[41,26],"class_list":["post-28766","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-leggisentenze","tag-spesa-farmaceutica"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/28766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=28766"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/28766\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/28772"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=28766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=28766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=28766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}